Razavi Journal of Medicine

Razavi Journal of Medicine

Effect of Intraoperative Remifentanil on Postoperative Pain and Analgesic Requirements in Colorectal Surgery: A Cohort Study

Document Type : Original Article

Authors
1 Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
3 Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract
Background: Remifentanil is an ultra-short-acting, high-potency opioid. Short-acting drugs such as Remifentanil can cause acute drug tolerance or opioid-induced hyperalgesia, thereby affecting postoperative pain.

Objective: This study aimed to compare postoperative pain in patients receiving propofol-remifentanil anesthesia versus Propofol alone.

Methods & Materials: This cohort study was performed on 35 patients admitted to the central operating room of Ghaem Hospital. Samples were selected from among the patients for two groups: those receiving Remifentanil plus Propofol and those receiving Propofol alone during surgery. The amount of analgesia received was recorded at 0, 30, 60, 120 minutes, and 6 and 12 hours after surgery. The patient's pain was also assessed using the VAS questionnaire at the same time. Data were analyzed using SPSS software version 23.

Results: In total, 60% (21 patients) were male, and 40% (14 patients) were female, with a mean age of 56.88 ± 17.88 years. The two groups were homogeneous in terms of age, sex, and weight. The two groups were also not statistically different in surgery duration, duration of anesthesia, or propofol dose. No significant difference was observed between the two groups in terms of intravenous Acetaminophen and meperidine intake at 0, 30, 60, 120 minutes, 6 hours, and 12 hours. There was no significant difference between the two groups in terms of ketorolac 30 mg and methadone. Although VAS scores in the Remifentanil + propofol group were lower than those in the propofol group at the final time points of 2, 6, and 12 hours, group (Propofol only or Remifentanil + propofol) did not affect VAS scores.

Conclusion: The study results showed that when an intermediate dose of Remifentanil (0.1 µg/kg/min) was combined with Propofol, no evidence of post-operative hyperalgesia was observed. Therefore, it is recommended that Remifentanil be preferably used in combination with Propofol.
Keywords

Acknowledgement: The authors would like to thank the Clinical Research Development Unit of Ghaem Hospital for cooperation in data analysis.This study was conducted as part of the corresponding author's clinical medical specialty thesis. Mashhad University of Medical Sciences financially supported it.


Ethical Considerations: All procedures were conducted in accordance with the Declaration of Helsinki. This study was reviewed and approved by the Ethics Committee of Mashhad University of Medical Sciences with the approval code IR.MUMS.MEDICAL.REC.1398.325. Informed consent was obtained from all patients before they participated in the study. Patients were assured that their information would remain confidential.


Data Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/


Conflicts of Interest: The authors declare that they have no conflicts of interest.


Funding: This study was conducted as part of the corresponding author’s clinical medical specialty thesis and was financially supported by Mashhad University of Medical Sciences, Mashhad, Iran.


Consent for Publication: Not applicable.


Author Contributions: S.J.P.F.: Conceptualization, study design, data collection, and manuscript preparation.B.E.: Methodology, data collection, and investigation.M.E.: Statistical analysis, data interpretation, and manuscript review.M.S.M.: Supervision, critical revision of the manuscript, and final approval of the version to be published. All authors contributed to the study, critically reviewed the manuscript, approved the final version, and agreed to be accountable for all aspects of the work.

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1. Yu EH, Tran DH, Lam SW, Irwin MG. Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain? Anaesthesia. 2016 Nov;71(11):1347-1362. doi: 10.1111/anae.13602. PMID: 27734470.
https://doi.org/10.1111/anae.13602
PMid:27734470
 
2. Santonocito C, Noto A, Crimi C, Sanfilippo F. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies. Local Reg Anesth. 2018 Apr 9;11:15-23. doi: 10.2147/LRA.S143618. PMID: 29670398; PMCID: PMC5898588.
https://doi.org/10.2147/LRA.S143618
PMid:29670398 PMCid:PMC5898588
 
 
3. Vincent J-L, Abraham E, Kochanek P, Moore FA, Fink MP. Textbook of Critical Care E-Book: Elsevier Health Sciences; 2016.  
 
4. Kido K, Toda S, Shindo Y, Miyashita H, Sugino S, Masaki E. Effects of low-dose ketamine infusion on remifentanil-induced acute opioid tolerance and the inflammatory response in patients undergoing orthognathic surgery. J Pain Res. 2019 Jan 17;12:377-385. doi: 10.2147/JPR.S177098. PMID: 30705603; PMCID: PMC6342226.
https://doi.org/10.2147/JPR.S177098
PMid:30705603 PMCid:PMC6342226
 
 
5. Liang M, Li CY, Ren CG, Zhang ZW, Fu ZJ. The effect of intraperitoneal chemotherapy on early pain hyperalgesia in patients following elective laparoscopic transabdominal resection of rectal cancer. Oncotarget. 2017 Jun 8;8(31):51869-51877. doi: 10.18632/oncotarget.18417. PMID: 28881696; PMCID: PMC5584297.
https://doi.org/10.18632/oncotarget.18417
PMid:28881696 PMCid:PMC5584297
 
 
6. Rauf K, Vohra A, Fernandez-Jimenez P, O'Keeffe N, Forrest M. Remifentanil infusion in association with fentanyl-propofol anesthesia in patients undergoing cardiac surgery: effects on morphine requirement and postoperative analgesia. Br J Anaesth. 2005 Nov;95(5):611-5. doi: 10.1093/bja/aei237. Epub 2005 Sep 9. PMID: 16155034.
https://doi.org/10.1093/bja/aei237
PMid:16155034
 
 
7. Wilson SH, Hellman KM, James D, Adler AC, Chandrakantan A. Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia. Pain Manag. 2021 Apr;11(4):405-417. doi: 10.2217/pmt-2020-0105. Epub 2021 Mar 29. PMID: 33779215; PMCID: PMC8023328.
https://doi.org/10.2217/pmt-2020-0105
PMid:33779215 PMCid:PMC8023328
 
 
8. Horii Y, Matsuda M, Takemura H, Ishikawa D, Sawa T, Amaya F. Spinal and Peripheral Mechanisms Individually Lead to the Development of Remifentanil-induced Hyperalgesia. Neuroscience. 2020 Oct 15;446:28-42. doi: 10.1016/j.neuroscience.2020.08.014. Epub 2020 Aug 18. PMID: 32818602.
https://doi.org/10.1016/j.neuroscience.2020.08.014
PMid:32818602
 
 
9. Ishida R, Nikai T, Hashimoto T, Tsumori T, Saito Y. Intravenous infusion of Remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats. Anesth Analg. 2012 Jan;114(1):224-9. doi: 10.1213/ANE.0b013e318237f678. Epub 2011 Oct 24. PMID: 22025495.
https://doi.org/10.1213/ANE.0b013e318237f678
PMid:22025495
 
 
10. Barakat A, Hamdy MM, Elbadr MM. Uses of fluoxetine in nociceptive pain management: A literature overview. Eur J Pharmacol. 2018 Jun 15;829:12-25. doi: 10.1016/j.ejphar.2018.03.042. Epub 2018 Mar 30. PMID: 29608897.
https://doi.org/10.1016/j.ejphar.2018.03.042
PMid:29608897
 
 
11. Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ, Yoon JW, Kim KH, Kwon JY. Maintenance anesthetics during remifentanil-based anesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth. 2010 Nov;105(5):661-7. doi: 10.1093/bja/aeq257. Epub 2010 Sep 28. PMID: 20876698.
https://doi.org/10.1093/bja/aeq257
PMid:20876698
 
 
12. Lee C, Song YK, Lee JH, Ha SM. The effects of intraoperative adenosine infusion on acute opioid tolerance and opioid induced hyperalgesia induced by Remifentanil in adult patients undergoing tonsillectomy. Korean J Pain. 2011 Mar;24(1):7-12. doi: 10.3344/kjp.2011.24.1.7. Epub 2011 Feb 25. PMID: 21390173; PMCID: PMC3049980.
https://doi.org/10.3344/kjp.2011.24.1.7
PMid:21390173 PMCid:PMC3049980
 
 
13. Song YK, Lee C, Seo DH, Park SN, Moon SY, Park CH. Interaction between postoperative shivering and hyperalgesia caused by high-dose Remifentanil. Korean J Anesthesiol. 2014 Jan;66(1):44-51. doi: 10.4097/kjae.2014.66.1.44. Epub 2014 Jan 28. PMID: 24567813; PMCID: PMC3927001.
https://doi.org/10.4097/kjae.2014.66.1.44
PMid:24567813 PMCid:PMC3927001
 
 
14. Welzing L, Link F, Junghaenel S, Oberthuer A, Harnischmacher U, Stuetzer H, Roth B. Remifentanil-induced tolerance, withdrawal or hyperalgesia in infants: a randomized controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of pediatric intensive care patients. Neonatology. 2013;104(1):34-41. doi: 10.1159/000348790. Epub 2013 Apr 26. PMID: 23635551.
https://doi.org/10.1159/000348790
PMid:23635551
 
 
15. Zhu K, Wen X, Mei X, Fang F, Zhang T. Mechanisms of Remifentanil-Induced Postoperative Hyperalgesia: A Comprehensive Review. Drug Des Devel Ther. 2025 Aug 27;19:7445-7457. doi: 10.2147/DDDT.S550335. PMID: 40901267; PMCID: PMC12400444.
https://doi.org/10.2147/DDDT.S550335
PMid:40901267 PMCid:PMC12400444
 
 
16. Su X, Zhu W, Tian Y, Tan L, Wu H, Wu L. Regulatory effects of Propofol on high-dose remifentanil-induced hyperalgesia. Physiol Res. 2020 Feb 19;69(1):157-164. doi: 10.33549/physiolres.934133. Epub 2019 Dec 19. PMID: 31852207; PMCID: PMC8565952.
https://doi.org/10.33549/physiolres.934133
PMid:31852207 PMCid:PMC8565952
 
 
17. Ruíz-López P, Navarrete-Calvo R, Morgaz J, Domínguez JM, Quirós-Carmona S, Muñoz-Rascón P, Gómez-Villamandos RJ, Fernández-Sarmiento JA, Granados MM. Determination of acute tolerance and hyperalgesia to remifentanil constant rate infusion in dogs undergoing sevoflurane anaesthesia. Vet Anaesth Analg. 2020 Mar;47(2):183-190. doi: 10.1016/j.vaa.2019.09.005. Epub 2019 Nov 12. PMID: 32005619.
https://doi.org/10.1016/j.vaa.2019.09.005
PMid:32005619
 
 
18. Kim D, Lim HS, Kim MJ, Jeong W, Ko S. High-dose intraoperative remifentanil infusion increases early postoperative analgesic consumption: a prospective, randomized, double-blind controlled study. J Anesth. 2018 Dec;32(6):886-892. doi: 10.1007/s00540-018-2569-6. Epub 2018 Oct 29. PMID: 30374890.
https://doi.org/10.1007/s00540-018-2569-6
PMid:30374890
 
 
19. Zhou J, Qi F, Hu Z, Zhang L, Li Z, Wang ZJ, Tang H, Chen Z. Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKα. Eur J Pharmacol. 2020 Feb 15;869:172882. doi: 10.1016/j.ejphar.2019.172882. Epub 2019 Dec 19. Erratum in: Eur J Pharmacol. 2021 Oct 5;908:174359. doi: 10.1016/j.ejphar.2021.174359. PMID: 31863769.
https://doi.org/10.1016/j.ejphar.2021.174359
PMid:34298417
 
 
20. Wu Z, Yu J, Lin Q, Li H, Zhang T, Tan H, Lin W, Cao L. Effects of an Intraoperative Intravenous Bolus Dose of Dexmedetomidine on Remifentanil-Induced Postinfusion Hyperalgesia in Patients Undergoing Thyroidectomy: A Double-Blind Randomized Controlled Trial. Anesth Analg. 2021 Feb 1;132(2):320-328. doi: 10.1213/ANE.0000000000005003. Erratum in: Anesth Analg. 2022 Feb 1;134(2):e13. doi: 10.1213/ANE.0000000000005834. PMID: 32639389.
https://doi.org/10.1213/ANE.0000000000005834
PMid:35030133
 
 
21. Wong SSC, Chan WS, Irwin MG, Cheung CW. Total Intravenous Anesthesia (TIVA) With Propofol for Acute Postoperative Pain: A Scoping Review of Randomized Controlled Trials. Asian J Anesthesiol. 2020 Sep 1;58(3):79-93. doi: 10.6859/aja.202009_58(3).0001. Epub 2020 Nov 3. PMID: 33176410.  
 
22. Echevarría G, Elgueta F, Fierro C, Bugedo D, Faba G, Iñiguez-Cuadra R, Muñoz HR, Cortínez LI. Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br J Anaesth. 2011 Dec;107(6):959-65. doi: 10.1093/bja/aer323. Epub 2011 Sep 28. PMID: 21965050.
https://doi.org/10.1093/bja/aer323
PMid:21965050
 
 
23. Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014 Jun;112(6):991-1004. doi: 10.1093/bja/aeu137. PMID: 24829420.
https://doi.org/10.1093/bja/aeu137
PMid:24829420
 
 
24. Gorsky K, Black ND, Niazi A, Saripella A, Englesakis M, Leroux T, Chung F, Niazi AU. Psychological interventions to reduce postoperative pain and opioid consumption: a narrative review of literature. Reg Anesth Pain Med. 2021 Oct;46(10):893-903. doi: 10.1136/rapm-2020-102434. Epub 2021 May 25. PMID: 34035150.
https://doi.org/10.1136/rapm-2020-102434
PMid:34035150
 
 
 

Articles in Press, Accepted Manuscript
Available Online from 20 August 2026